Pennant Investors »

Fibrogen shares owned by Pennant Investors

Quarter-by-quarter ownership of Fibrogen (FGEN) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Fibrogen

Tip: Access up to 7 years of quarterly data

All positions including Fibrogen held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrogen by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 768k 2.35

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Fibrogen

PRIMECAP Management Company
Armistice Capital
BlackRock
Vanguard Group
Acadian Asset Management
Citadel Advisors
Jacobs Levy Equity Management
Geode Capital Management
683 Capital Management
Two Sigma Advisers
Point72 Asset Management
Two Sigma Investments
Pennant Investors
Northern Trust
AQR Capital Management

View all funds holding Fibrogen